STOCKS TELEGRAPH

Tag: AMPE

  • Ampio Pharmaceuticals Inc. (AMPE) Collapse After Hours on Regulatory Update

    On April 20, the biopharma, Ampio Pharmaceuticals Inc. (AMPE) provided regulatory updates regarding the Type C meeting request for AP-013. Upon news of receiving a complete response letter from the FDA, AMPE stock collapsed in the after hours. Thus, the stock declined by a huge 36.78% at a heavy volume of 3,13 million shares. APME then reached a new low of $0.22 per share in the session while the previous low was $0.33.

    AMPE’s Regulatory Update

    The company had recently submitted a Type C meeting request for clarity on the acceptability of the proposed mITT population as the primary analysis population. Furthermore, in addition to the proposed population being the primary population for assessing the efficacy of the AP-013 trial, the acceptability of AP-013 as a second trial to support BLA for Ampion was also part of the discussion.

    Source: Florence Healthcare

    In the complete response letter to the request, FDA did not agree with changing the intent-to-treat population to a modified intent-to-treat population. Furthermore, the FDA also said that before analyzing and unbinding the data AMPE should have sought FDA’s approval. Additionally, the FDA also did not agree to AP-013 being a second pivotal trial for Ampion.

    Hence, based on FDA’s response, the company now feels the AP-013 trial’s salvation as a pivotal trial now seems highly unlikely. Despite the disappointing response, the company now plans to assess its various options for salvaging the trial while keeping FDA in the loop.

    However, according to Chairman and CEO, Mike Martino, the best path forward seems to be a new Phase 3 trial.

    Market Analysis

    The global biopharmaceutical market is expected to deliver a health CAGR of 9.5% from 2022 to 2028 while it generated $298.50 billion in 2021. On the other hand, the osteoarthritis market is also showing alarming growth as the elderly population continues rising. Another concerning factor is that the disease is on the rise in the younger population as well while previously it was thought that aging is responsible for the disease as general bone health tends to deteriorate with it. The near past has shown a varying trend with the degenerative bones disease being increasingly found in the young population. The possible cause of this is a sedentary lifestyle with people sitting for long hours on top of rising obesity.

    Conclusion

    While there lies a huge market opportunity to leverage, AMPE is struggling to complete the development of Ampion for severe Arthritis of the knee. After hitting another setback in the regulatory process, now the company thinks it can design and execute a trial that will possibly lead to BLA approval.

    The company had enough funds to run operations into the second half of 2023.

  • Positive Phase 3 AP-013 Data: Ampio Pharmaceuticals Inc. (AMPE) stock Advances Further After Hours

    Positive Phase 3 AP-013 Data: Ampio Pharmaceuticals Inc. (AMPE) stock Advances Further After Hours

    On March 02, Ampio Pharmaceuticals Inc. (AMPE) announced positive data from Phase 3 clinical trial of AmpionTM in severe osteoarthritis of the knee (OAK). Consequently, the stock remained bullish in the following sessions.

    During the regular session, the stock fluctuated between a high of $0.51 and a low of $0.45. At an above-average volume of 5.9 million shares, AMPE stock closed the session in the green with a good gain of 10.33%. After closing the session at a value of $0.50 per share, the stock continued to hike in the after hours. As the company held a webinar in the after-hours to discuss the data along with its analysis, the stock added a further 21.00%. Hence, the stock was trading at $0.61 apiece in the after-hours on Wednesday. The after-hours volume remained more than the regular session’s average at 3.68 million shares.

    The biopharmaceutical company, Ampio Pharmaceuticals Inc. has a market capitalization of $103.34 million. Currently, the company has 227.13 million shares outstanding in the market. In the past five days, the stock has added 16.74% while losing 11.93% year to date.

    AP-013 Positive Data

    The company’s AP-013 study was designed for the confirmation of the efficacy of Ampion as observed in the first AP-003-A trial. Moreover, the trial was also detecting the difference between Apmion and saline control.

    Source: Ophthalmology Times

    Commenced in June 2019, the trial suffered a loss of huge data due to the pandemic. As per the FDA’s recommendation, the company conducted a sensitivity analysis for the impact of Covid-19 on the study. Thus, AMPE proposed a modified Intent-to-Treat (mITT) population for evaluating the efficacy.

    On Wednesday, the company reported positive data from the mITT population in its phase 3 AP-013 trial. The data confirmed the results of AP-003-A and supported the safety and efficacy of Ampion for the treatment of OAK.

    Additionally, FDA has confirmed the company’s Type C Meeting request.

    AMPE Financial Summary

    On November 10, 2021, the company declared its financial results for the third quarter of 2021 along with future guidance.

    In Q3 2021, AMPE incurred a net loss of $0.02 per diluted share against $0.06 in the previous-year period.

    The company had cash and cash equivalents of $17.1 million at the end of Q3 2021. AMPE believed the cash and cash equivalents along with external sources of liquidity to be enough for funding its operations through Q1 2023.

  • 26 stocks trending in pre-market

    ‎Bionano Genomics Inc. (BNGO) stock soared 13.81% to $2.39 in the pre-‎market ‎trading following an announcement from the firm that Nasdaq has granted the Company an ‎additional ‎‎180-day compliance period, or until June 28, 2021. The most recent rating by Ladenburg ‎Thalmann, on ‎September 24, 2020, is a Buy. ‎

    Before the trading started on December 31, 2020, fuboTV Inc. (FUBO) is down -‎‎‎2.43% to reach $32.5. It has been trading in a 52-week range of $5.00 to $62.29.‎

    ‎Guardion Health Sciences Inc. (NASDAQ: GHSI) shares are trading down -10.77% ‎at ‎‎$0.5247 at the time of writing. The firm lately revealed the appointment of Bret Scholtes as ‎its ‎President and Chief Executive Officer, and as a member of the Board of Directors. Company’s 52-‎week ‎ranged between $0.17 to $0.74.‎

    ‎Nxt-ID Inc. (NXTD) stock soared 7.1% to $1.81 in the pre-market trading. ‎The ‎most ‎recent rating by Maxim Group, on November 20, 2017, is a Buy.‎

    ‎Castor Maritime Inc. (CTRM) grew over 41.75% at $0.33 in pre-market trading ‎today ‎after receiving 180-day extension from Nasdaq to meet Nasdaq minimum bid price rule. ‎

    ‎Net Element Inc. (NASDAQ: NETE) shares are trading down -5.21% at $15.45 at ‎the ‎time of writing. Company’s 52-week ranged between $1.47 to $20.08. ‎

    ‎Sundial Growers Inc. (SNDL) stock moved down -1.36 percent to $0.4784 in the pre-‎‎market trading following the declaration from the company that it has closed the acquisition of ‎a ‎special purpose vehicle. ‎

    ‎Professional Diversity Network Inc. (IPDN) gained over 14.96% at $3.15 in pre-‎‎market trading Thursday December 31, 2020 after the firm revealed its partnership with ‎Phala ‎Network.‎

    ‎Marathon Patent Group Inc. (MARA) is up more than 7.63% at $11.71 in pre-‎market ‎hours Thursday December 31, 2020. The company recently revealed that it has entered into a ‎contract ‎with Bitmain to purchase 70,000 Antminer S-19 ASIC miners. The stock had dropped over -‎‎7.48% to ‎‎$10.88 in the last trading session.‎

    ‎Riot Blockchain Inc. (RIOT), a Software – Application company, rose about ‎‎4.92% ‎at ‎‎$18.11 in pre-market trading Thursday.‎

    ‎Nano Dimension Ltd. (NNDM) stock moved up 2.09 percent to $9.75 in the pre-‎‎market trading after closing $250 million registered direct offering.‎

    ‎AIkido Pharma Inc. (AIKI) gained over 33.72% at $1.15 in pre-‎‎market ‎trading ‎Thursday December 31, 2020.‎

    ‎Color Star Technology Co. Ltd. (NASDAQ: CSCW) shares are trading down -4.38% ‎at ‎‎$0.8032 at the time of writing after declaring strategic partnership with two UAE ‎companies. ‎Company’s 52-week ranged between $0.31 to $2.06.‎

    ‎IMAC Holdings Inc. (IMAC) stock moved down -4.08 percent to $1.41 in the pre-‎‎market trading after reporting completion of first infusion of Stem Cells in clinical study for ‎the ‎treatment of Bradykinesia due to Parkinson’s disease.‎

    ‎Ampio Pharmaceuticals Inc. (AMPE) stock soared 12.84% to $1.67 in the pre-‎market ‎trading. The firm recently revealed that it has received guidance from the U.S Food & ‎Drug ‎Administration regarding the impact of COVID-19 on its Phase III clinical trial for osteoarthritis of ‎the ‎knee. The most recent rating by ROTH Capital, on December 19, 2019, is a Buy.‎

    ‎Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares are trading up 5.76% ‎at ‎‎$49.4 at the time of writing after the company announced that it would develop a therapeutic spray ‎as ‎a candidate to treat the hereditary lung and digestive-system disease cystic fibrosis. Company’s 52-‎‎week ranged between $8.51 to $129.71. Analysts have a consensus price target of $69. ‎

    Before the trading started on December 31, 2020, Baidu Inc. (BIDU) is up ‎‎3.53% ‎to ‎reach $227.38. It has been trading in a 52-week range of $82.00 to $202.79.‎

    ‎Greenpro Capital Corp. (GRNQ) is up more than 3.11% at $1.99 in pre-market ‎hours ‎Thursday December 31, 2020. The company lately revealed that it intends to set up a Bitcoin ‎‎($BTC) ‎Fund for investment. The stock had jumped over 3.76% to $1.93 in the last trading session.‎

    ‎Onconova Therapeutics Inc. (ONTX) is down more than -3.79% at $0.49 in pre-‎‎market hours Thursday December 31, 2020. The stock had jumped over 18.88% to $0.51 in the ‎last ‎trading session.‎

    ‎JinkoSolar Holding Co. Ltd. (JKS) grew over 2.28% at $65.55 in pre-market ‎trading ‎today. The firm recently revealed annual general meeting 2020 ‎results.‎

    ‎Tonix Pharmaceuticals Holding Corp. (TNXP) lost over -2.76% at $0.6632 in pre-‎‎market trading Thursday December 31, 2020.‎

    ‎Osmotica Pharmaceuticals plc (OSMT) stock moved down -2.13 percent to $4.14 ‎in ‎the pre-market trading after declaring that the U.S. Food and Drug Administration (FDA) has ‎declined ‎to approve one of its products. ‎

    ‎Cinedigm Corp. (CIDM) is down more than -0.69% at $0.62 in pre-‎market ‎hours ‎Thursday December 31, 2020. The stock had dropped over -9.51% to $0.62 in the last ‎trading ‎session.‎

    ‎Novan Inc. (NOVN), a Biotechnology company, dropped about -7.71% at $0.969 ‎in ‎pre-market trading Thursday.‎

    Before the trading started on December 31, 2020, Canaan Inc. (CAN) is ‎up ‎‎25.57% ‎to ‎reach $5.5. It has been trading in a 52-week range of $1.76 to $8.69.‎

    ‎500.com Limited (WBAI) gained over 5.12% at $8.0 in pre-market trading ‎Thursday ‎December 31, 2020. The company recently declared that Mr. Zhaofu Tian has resigned as ‎Chief ‎Technology Officer of the Company due to personal reasons.‎

  • Pre-Market Cues: 24 Stocks Roaring for Change On December 28th

    Pre-Market Cues: 24 Stocks Roaring for Change On December 28th

    ‎Avinger Inc. (AVGR) stock plunged -7.38% to $0.4445 in the pre-market trading. The ‎most recent rating by Ladenburg Thalmann, on March 09, 2018, is a Buy. The company lately ‎announced annual meeting results.‎

    ‎Jaguar Health Inc. (JAGX) is up more than 16.5% at $0.833 in pre-market ‎hours ‎Monday December 28, 2020 after signing second agreement for $6 million non-dilutive ‎financing ‎transaction involving the sale of royalty rights. The stock had dropped over -33.18% to $0.71 ‎in the last ‎trading session.‎

    ‎Ocugen Inc. (NASDAQ: OCGN) shares are trading up 52.84% at $2.69 at the time of ‎writing. Company’s 52-week ranged between $0.17 to $3.05.‎

    ‎Senseonics Holdings Inc. (SENS) tumbled over -13.63% at $0.786 in pre-market ‎trading today after declaring financial and operational business updates.‎

    ‎Naked Brand Group Limited (NAKD), a Apparel Manufacturing company, rose about ‎‎2.63% at $0.2145 in pre-market trading Monday after reporting that it has been granted an additional ‎‎180-day period, or until May 24, 2021.‎

    ‎Zomedica Corp. (ZOM) gained over 13.05% at $0.259 in pre-market trading Monday ‎December 28, 2020.‎

    Before the trading started on December 28, 2020, Sundial Growers Inc. (SNDL) is up ‎‎9.23% to reach $0.517. The company today declared concentrates license agreement with Simply ‎Solventless. It has been trading in a 52-week range of $0.14 to $3.88.‎

    ‎Acasti Pharma Inc. (ACST) stock soared 14.17% to $0.377 in the pre-market trading. ‎The most recent rating by Oppenheimer, on September 01, 2020, is a Perform.‎

    ‎Camber Energy Inc. (AMEX: CEI) shares are trading down -7.62% at $0.97 at the time ‎of writing. Company’s 52-week ranged between $0.46 to $4.10.‎

    ‎NIO Limited (NIO), a Auto Manufacturers company, rose about 1.92% at $46.65 in ‎pre-market trading Monday.‎

    ‎FuelCell Energy Inc. (FCEL) stock moved up 10.0 percent to $13.53 in the pre-market ‎trading.‎

    ‎Tonix Pharmaceuticals Holding Corp. (TNXP) gained over 7.86% at $0.7173 in pre-‎market trading Monday December 28, 2020. The firm recently revealed that it has completed the ‎purchase of an approximately 44-acre site in Hamilton, Montana, for the construction of a vaccine ‎development and commercial scale manufacturing facility. ‎

    ‎Guardion Health Sciences Inc. (GHSI) is down more than -9.47% at $0.3097 in pre-‎market hours Monday December 28, 2020. The stock had dropped over -7.89% to $0.34 in the last ‎trading session.‎

    Before the trading started on December 28, 2020, Color Star Technology Co. Ltd. ‎‎(CSCW) is up 30.76% to reach $0.9284. It has been trading in a 52-week range of $0.31 to ‎‎$2.06.‎

    ‎Ampio Pharmaceuticals Inc. (AMPE) stock soared 8.49% to $2.3 in the pre-market ‎trading. The most recent rating by ROTH Capital, on December 19, 2019, is a Buy.‎

    ‎Blink Charging Co. (BLNK), a Specialty Retail company, rose about 4.24% at $51.6 in ‎pre-market trading Monday.‎

    ‎Nikola Corporation (NKLA) stock moved up 2.18 percent to $14.05 in the pre-market ‎trading.‎

    ‎Onconova Therapeutics Inc. (ONTX) gained over 3.39% at $0.4905 in pre-market ‎trading Monday December 28, 2020.‎

    Before the trading started on December 28, 2020, MicroVision Inc. (MVIS) is up ‎‎4.43% to reach $6.84. It has been trading in a 52-week range of $0.15 to $9.74.‎

    ‎Nano Dimension Ltd. (NNDM) stock plunged -13.51% to $7.62 in the pre-market ‎trading after pricing $250 million registered direct offering. The most recent rating by Maxim Group, on ‎October 21, 2016, is a Buy.‎

    ‎Plug Power Inc. (NASDAQ: PLUG) shares are trading up 5.37% at $37.49 at the time ‎of writing. Company’s 52-week ranged between $2.53 to $37.11. Analysts have a consensus price ‎target of $24.‎

    ‎Marathon Patent Group Inc. (MARA) grew over 31.23% at $14.33 in pre-market ‎trading today.‎

    ‎Riot Blockchain Inc. (RIOT), a Software – Application company, rose about 18.22% at ‎‎$15.51 in pre-market trading Monday.‎

    ‎Marathon Oil Corporation (MRO) stock moved up 3.32 percent to $6.85 in the pre-‎market trading.‎

  • Pre-Market Cues: 28 Stocks Roaring for Change On December 18th

    Pre-Market Cues: 28 Stocks Roaring for Change On December 18th

    Seneca Biopharma Inc. (SNCA), a Biotechnology company, rose about 0.2% at $0.96 in pre-market trading Friday after declaring merger agreement with Leading BioSciences, Inc. under which a wholly owned subsidiary of Seneca will merge with LBS in an all-stock transaction.

    Palantir Technologies Inc. (PLTR) lost over -3.97% at $26.15 in pre-market trading Friday December 18, 2020 after reporting that it will hold its inaugural “Live Demo Day” on Tuesday, January 26, 2021 at 4:30pm ET.

    Atossa Therapeutics Inc. (ATOS) stock plunged -0.02% to $0.86 in the pre-market trading following its declaration of pricing of $14.0 million registered direct offering priced at-the-market. The most recent rating by Maxim Group, on January 26, 2018, is a Buy.

    Virgin Galactic Holdings Inc. (NYSE: SPCE) shares are trading down -6.27% at $23.9 at the time of writing. The company recently revealed an update following its test flight on December 12, 2020. Company’s 52-week ranged between $9.06 to $42.49. Analysts have a consensus price target of $19.

    BlackBerry Limited (BB), a Software – Infrastructure company, dropped about -4.36% at $7.9 in pre-market trading Friday after releasing its financial results for the three months ended November 30, 2020

    Before the trading started on December 18, 2020, Uxin Limited (UXIN) is up 4.5% to reach $1.16 following its announcement of unaudited financial results for the quarter ended September 30, 2020. It has been trading in a 52-week range of $0.72 to $3.07.

    Coeur Mining Inc. (CDE) stock plunged -2.98% to $10.76 in the pre-market trading. The firm recently revealed details of the expansion of its Rochester silver-gold mine in Nevada, reflecting significant reserve growth and the benefits of a larger-scale expansion project. The most recent rating by Noble Capital Markets, on September 14, 2020, is an Outperform.

    Novan Inc. (NASDAQ: NOVN) shares are trading up 6.25% at $0.68 at the time of writing. The company lately reported that it has enrolled 525 patients of the approximately 850 patients expected to enroll in the B-SIMPLE4 pivotal Phase 3 clinical study of SB206. Company’s 52-week ranged between $0.22 to $3.72.

    CNS Pharmaceuticals Inc. (CNSP), a Biotechnology company, rose about 15.2% at $2.88 in pre-market trading Friday after announcing FDA approval of IND application for its brain cancer drug candidate Berubicin.

    United States Steel Corporation (X) stock moved down -4.26 percent to $17.77 in the pre-market trading after reporting that fourth quarter 2020 adjusted EBITDA is expected to be approximately $55 million and expected fourth quarter 2020 adjusted diluted loss per share to be approximately ($0.85).

    BioCardia Inc. (BCDA) lost over -6.09% at $4.01 in pre-market trading Friday December 18, 2020 following an announcement from the firm that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the Phase III pivotal CardiAMP Heart Failure Trial.

    Before the trading started on December 18, 2020, Ampio Pharmaceuticals Inc. (AMPE) is up 8.43% to reach $1.93 after revealing the completion of its Phase I clinical trial and initiation of the first steps for a global Phase II clinical trial for intravenous (“IV”) Ampion treatment in COVID-19 patients. It has been trading in a 52-week range of $0.31 to $1.69.

    Drive Shack Inc. (NYSE: DS) shares are trading up 5.47% at $3.47 at the time of writing following the opening of its 65,000-square-foot entertainment golf venue located in Orlando. Company’s 52-week ranged between $0.86 to $4.19. Analysts have a consensus price target of $4.

    IZEA Worldwide Inc. (IZEA) tumbled over -3.7% at $1.04 in pre-market trading today. The company recently reported that it has just been awarded a mid-six figure contract from a Fortune 500 Manufacturer.

    Exela Technologies Inc. (XELA), a Software – Application company, rose about 81.87% at $0.66 in pre-market trading Friday after declaring that it has entered into a 5-year, $145 million term loan facility with Angelo Gordon, a global alternative investment firm.

    FedEx Corporation (FDX) stock moved down -2.89 percent to $283.8 in the pre-market trading after declaring strong results for the quarter ended November 30.

    Guardion Health Sciences Inc. (GHSI) stock plunged -2.13% to $0.23 in the pre-market trading. The firm recently declared progress on the introduction of its new vision support/energy drink, Epiq-V, which is under development for the United States and international markets.

    Amyris Inc. (NASDAQ: AMRS) shares are trading up 3.68% at $4.23 at the time of writing. Company’s 52-week ranged between $1.40 to $6.07. Analysts have a consensus price target of $3.35.

    Mereo BioPharma Group plc (MREO), a Biotechnology company, rose about 40.27% at $3.1 in pre-market trading Friday following the declaration of a license and collaboration agreement with Ultragenyx Pharmaceutical Inc. (RARE), for setrusumab, a monoclonal antibody in clinical development for osteogenesis imperfecta (OI).

    Surface Oncology Inc. (SURF) gained over 17.51% at $10.0 in pre-market trading Friday December 18, 2020 after revealing exclusive license agreement with GSK for novel immunotherapy program.

    Neovasc Inc. (NVCN) is down more than -8.52% at $0.91 in pre-market hours Friday December 18, 2020 after reporting the publication of peer-reviewed article in EuroIntervention. The stock had jumped over 3.61% to $0.99 in the last trading session.

    BioLineRx Ltd. (BLRX) tumbled over -1.1% at $2.7 in pre-market trading today. The firm lately declared final results from Phase 2a COMBAT/KEYNOTE-202 triple combination study of Motixafortide in second line Metastatic Pancreatic Cancer (PDAC).

    VYNE Therapeutics Inc. (VYNE), a Biotechnology company, rose about 8.05% at $1.88 in pre-market trading Friday after declaring the successful completion of its End-of-Phase 2 Meeting with the U.S. Food and Drug Administration (FDA).

    Before the trading started on December 18, 2020, Mesoblast Limited (MESO) is down -26.75% to reach $9.94 after announcing an update on COVID-19 ARDS trial. It has been trading in a 52-week range of $3.12 to $21.28.

    Applied DNA Sciences Inc. (APDN) stock plunged -12.02% to $5.49 in the pre-market trading after reporting consolidated financial results for the full fiscal year and quarter ended September 30, 2020. The most recent rating by H.C. Wainwright, on July 20, 2020, is a Buy.

    Conformis Inc. (NASDAQ: CFMS) shares are trading up 3.8% at $0.6693 at the time of writing. The firm lately revealed the U.S. commercial launch of the Company’s new Cordera™ Match Hip System. Company’s 52-week ranged between $0.50 to $1.66.

    Auris Medical Holding Ltd. (EARS) grew over 1.5% at $2.7 in pre-market trading today. The company recently provided a business update related to the Company’s funding position, its AM-301 program for the protection against airborne pathogens and allergens and the ongoing strategy review process.

    Sonoma Pharmaceuticals Inc. (SNOA) stock moved up 19.79 percent to $9.14 in the pre-market trading following the announcement of partnership with Gabriel Science, LLC for dental.

  • 31 stocks trending in pre-market

    31 stocks trending in pre-market

    NIO Limited (NIO) stock soared 2.95% to $42.19 in the pre-market trading following the pricing of offering of 68,000,000 American depositary shares. The most recent rating by Goldman, on December 01, 2020, is a Neutral. NIO Inc.

    Veru Inc. (NASDAQ: VERU) shares are trading up 7.17% at $10.39 at the time of writing after declaring positive Phase 2 clinical trial results for enobosarm, for the treatment of endocrine and chemotherapy resistant ER+/HER2- metastatic breast cancer, which was selected as a Spotlight Presentation at the 2020 San Antonio Breast Cancer Symposium. Company’s 52-week ranged between $2.10 to $7.86. Analysts have a consensus price target of $6.

    Occidental Petroleum Corporation (OXY) stock soared 2.45% to $19.64 in the pre-market trading. The most recent rating by MKM Partners, on December 07, 2020, is a Neutral.

    BioCardia Inc. (BCDA), a Biotechnology company, rose about 9.38% at $4.9 in pre-market trading Tuesday after reporting entry into definitive agreements with investors for the purchase and sale of 1,789,474 shares of its common stock at a purchase price of $4.75 per share in a registered direct offering priced at-the-market under Nasdaq rules.

    Genius Brands International Inc. (GNUS) gained over 15.85% at $2.12 in pre-market trading Tuesday December 15, 2020. The company recently revealed that it has secured a commitment to receive $100 million in cash on January 15, 2021 from New York-based Mudrick Capital Management as a result of a new first lien debt financing.

    Nikola Corporation (NKLA) is up more than 2.38% at $16.8 in pre-market hours Tuesday December 15, 2020. The stock had dropped over -6.87% to $16.41 in the last trading session.

    Virgin Galactic Holdings Inc. (SPCE) is up more than 2.83% at $27.22 in pre-market hours Tuesday December 15, 2020 following an update on test flight program. The stock had dropped over -17.38% to $26.47 in the last trading session.

    Before the trading started on December 15, 2020, Huntington Bancshares Incorporated (HBAN) is up 2.32% to reach $12.8 after reporting merger with TCF Financial Corporation to create top 10 U.S. regional bank. It has been trading in a 52-week range of $6.82 to $15.63.

    Plug Power Inc. (PLUG) stock soared 2.65% to $26.38 in the pre-market trading. The most recent rating by B. Riley Securities, on November 10, 2020, is a Buy.

    XPeng Inc. (NYSE: XPEV) shares are trading up 3.86% at $48.99 at the time of writing after its P7 super-long range sports sedan received car of the Year 2021 award in Xuanyuan Awards. Company’s 52-week ranged between $17.11 to $74.49. Analysts have a consensus price target of $58.

    AnPac Bio-Medical Science Co. Ltd. (ANPC), a Biotechnology company, dropped about -5.26% at $5.4 in pre-market trading Tuesday following the proclamation from the firm that it has made significant progress in detecting pre-cancer diseases.

    Yamana Gold Inc. (AUY) stock moved up 2.66 percent to $5.4 in the pre-market trading.

    Zynga Inc. (ZNGA) gained over 3.9% at $9.05 in pre-market trading Tuesday December 15, 2020 following the declaration of pricing of offering of $762 million of convertible senior notes.

    IZEA Worldwide Inc. (IZEA) is down more than -5.68% at $0.9243 in pre-market hours Tuesday December 15, 2020 after announcing that it has seen a surge of new customers in Q4 2020. The stock had jumped over 15.00% to $0.98 in the last trading session.

    Cameco Corporation (CCJ) grew over 3.16% at $13.7 in pre-market trading today.

    Before the trading started on December 15, 2020, HEXO Corp. (HEXO) is down -2.8% to reach $0.9817 after releasing its first quarter fiscal 2021 financial results. It has been trading in a 52-week range of $0.35 to $2.30.

    Nano Dimension Ltd. (NNDM) stock soared 1.8% to $6.77 in the pre-market trading. The most recent rating by Maxim Group, on October 21, 2016, is a Buy.

    Teligent Inc. (TLGT) tumbled over -3.53% at $0.78 in pre-market trading today.

    Synlogic Inc. (NASDAQ: SYBX) shares are trading down -5.51% at $2.4 at the time of writing following advancement of SYNB1891 to combination arm dosing with PD-L1 checkpoint inhibitor in the on-going phase 1 study for the treatment of solid tumors and lymphoma. Company’s 52-week ranged between $1.35 to $3.99.

    BioNTech SE (BNTX) stock soared 5.48% to $114.2 in the pre-market trading. The most recent rating by BofA Securities, on December 01, 2020, is a Neutral. Pfizer Inc. (PFE) and BioNTech SE (BNTX) recently declared additional data on neutralizing antibody and T cell responses from the Phase 1/2 trial with BNT162b2 conducted in Germany

    Torchlight Energy Resources Inc. (TRCH) tumbled over -12.14% at $0.543 in pre-market trading today.

    Seelos Therapeutics Inc. (SEEL) stock moved up 5.47 percent to $1.35 in the pre-market trading after revealing the sale of a $12.0 million senior secured convertible note and shares of Seelos common stock to investors.

    Bed Bath & Beyond Inc. (BBBY) gained over 4.35% at $19.69 in pre-market trading Tuesday December 15, 2020 following the declaration of definitive agreement to sell its remaining non-core banner Cost Plus World Market (CPWM) to Kingswood Capital Management, a Los Angeles-based private equity firm.

    Before the trading started on December 15, 2020, Aerpio Pharmaceuticals Inc. (ARPO) is down -3.33% to reach $1.16. It has been trading in a 52-week range of $0.42 to $2.31.

    Before the trading started on December 15, 2020, Energy Fuels Inc. (UUUU) is up 2.94% to reach $3.15 after reporting that it has entered into a three-year supply agreement with The Chemours Company (CC) to acquire a minimum of 2,500 tons per year of natural monazite sands. It has been trading in a 52-week range of $0.78 to $3.10.

    Uranium Energy Corp. (UEC) grew over 5.62% at $1.69 in pre-market trading today after filing fiscal 2021 Q1 quarterly report.

    MicroVision Inc. (MVIS), a Scientific & Technical Instruments company, rose about 5.43% at $3.3 in pre-market trading Tuesday.

    NovaBay Pharmaceuticals Inc. (NBY) is down more than -2.28% at $0.68 in pre-market hours Tuesday December 15, 2020 after reporting that its proprietary hypochlorous acid solution has received U.S. Environmental Protection Agency (EPA) approval for a kill claim against SARS-CoV-2, the virus that causes COVID-19. The stock had jumped over 0.86% to $0.70 in the last trading session.

    vTv Therapeutics Inc. (VTVT), a Biotechnology company, dropped about -10.44% at $2.66 in pre-market trading Tuesday after declaring a licensing agreement with Anteris Bio for worldwide rights to vTv’s novel clinical-stage Nrf2 activator compound, HPP971.

    Socket Mobile Inc. (NASDAQ: SCKT) shares are trading down -15.38% at $2.42 at the time of writing. Company’s 52-week ranged between $0.76 to $4.50.

    ArcelorMittal (MT) grew over 4.3% at $22.08 in pre-market trading today after announcing investment agreement with Invitalia, an Italian state-owned company.

  • Pre-Market Cues: 30 Stocks Roaring for Change On December 14th

    Sonoma Pharmaceuticals Inc. (SNOA) stock plunged -7.53% to $8.1 in the pre-market trading after reporting partnership with Crown Laboratories to launch Microcyn® technology-based anti-itch over-the-counter products.

    Livent Corporation (NYSE: LTHM) shares are trading up 3.6% at $17.0 at the time of writing. Company’s 52-week ranged between $3.95 to $17.53. Analysts have a consensus price target of $16.50.

    Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) shares are trading down -5.45% at $2.95 at the time of writing after declaring offering of common stock. Company’s 52-week ranged between $1.03 to $5.31.

    NextDecade Corporation (NEXT) is down more than -7.25% at $3.2 in pre-market hours Monday December 14, 2020. The stock had jumped over 38.00% to $3.45 in the last trading session.

    FAT Brands Inc. (FAT) tumbled over -4.06% at $7.57 in pre-market trading today following the announcement from the company that it has entered into an agreement to combine with Fog Cutter Capital Group Inc. (FCCG), the Company’s controlling stockholder.

    Recro Pharma Inc. (REPH) stock soared 3.21% to $3.05 in the pre-market trading. The most recent rating by Stephens, on October 17, 2019, is an Overweight.

    Ampio Pharmaceuticals Inc. (AMPE) stock moved up 3.33 percent to $1.55 in the pre-market trading.

    ReTo Eco-Solutions Inc. (RETO), a Building Materials company, rose about 3.91% at $0.665 in pre-market trading Monday.

    Yiren Digital Ltd. (YRD) lost over -5.36% at $3.0 in pre-market trading Monday December 14, 2020. The firm recently announced that it has entered into two collaborative research agreements to explore new clinical indications for its immunomodulatory drug, Ampion™.

    Before the trading started on December 14, 2020, Sabre Corporation (SABR) is up 3.46% to reach $11.35. It has been trading in a 52-week range of $3.30 to $23.25.

    NantHealth Inc. (NH) is up more than 1.74% at $3.5 in pre-market hours Monday December 14, 2020. The company recently presented during a poster session at the San Antonio Breast Cancer Symposium (SABCS) new significant findings around the adoption of trastuzumab biosimilars in the treatment of HER2-positive breast cancer and the potential clinical and cost benefits of biosimilars. The stock had jumped over 22.42% to $3.44 in the last trading session.

    Torchlight Energy Resources Inc. (TRCH) stock soared 15.79% to $0.88 in the pre-market trading. The most recent rating by ROTH Capital, on March 13, 2020, is a Neutral.

    NIO Limited (NYSE: NIO) shares are trading down -6.38% at $39.3 at the time of writing following the announcement of pricing of offering of 68,000,000 American Depositary Shares. Company’s 52-week ranged between $2.11 to $57.20. Analysts have a consensus price target of $59.

    Lightbridge Corporation (LTBR) is down more than -2.4% at $3.66 in pre-market hours Monday December 14, 2020. The stock had jumped over 12.28% to $3.75 in the last trading session.

    Foresight Autonomous Holdings Ltd. (FRSX) stock moved up 2.31 percent to $1.77 in the pre-market trading after its affiliate, Rail Vision Ltd., has received an order from Knorr-Bremse Systeme für Schienenfahrzeuge GmbH, an affiliate of Knorr-Bremse AG (Frankfurt: KBX), for two samples of their light rail vehicle (LRV) system.

    Before the trading started on December 14, 2020, Hennessy Capital Acquisition Corp. IV (HCAC) is up 2.32% to reach $20.75. It has been trading in a 52-week range of $9.21 to $22.43.

    Inseego Corp. (INSG) stock soared 10.36% to $15.18 in the pre-market trading after reporting that the company is expanding its global footprint in Japan with the launch of its industry-leading 5G MiFi® M2000 mobile hotspot. The most recent rating by ROTH Capital, on August 06, 2020, is a Neutral.

    Mechel PAO (MTL) is down more than -3.66% at $1.84 in pre-market hours Monday December 14, 2020. The stock had jumped over 11.05% to $1.91 in the last trading session.

    JinkoSolar Holding Co. Ltd. (NYSE: JKS) shares are trading up 3.58% at $54.9 at the time of writing after declaring an update to 2020 annual general meeting agenda. Company’s 52-week ranged between $11.42 to $90.20. Analysts have a consensus price target of $55.

    Before the trading started on December 14, 2020, CureVac N.V. (CVAC) is up 6.7% to reach $125.99. It has been trading in a 52-week range of $36.15 to $151.80.

    Xeris Pharmaceuticals Inc. (XERS) grew over 2.84% at $4.7 in pre-market trading today after recent proclamation from company that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive Opinion for Ogluo™ (glucagon).

    Teligent Inc. (NASDAQ: TLGT) shares are trading up 85.54% at $1.17 at the time of writing. Company’s 52-week ranged between $0.46 to $6.46. Analysts have a consensus price target of $2.

    Marathon Patent Group Inc. (MARA) gained over 15.58% at $5.49 in pre-market trading Monday December 14, 2020. The firm recently announced a contract with Bitmain to purchase 10,000 Antminer S-19j Pro ASIC Miners.

    Sundial Growers Inc. (NASDAQ: SNDL) shares are trading up 4.64% at $0.53 at the time of writing after reporting that it has received approval to transfer the listing of its common shares to the Nasdaq Capital Market. Company’s 52-week ranged between $0.14 to $3.88.

    Neos Therapeutics Inc. (NEOS) tumbled over -5.61% at $0.6532 in pre-market trading today. The company and Aytu BioScience, Inc. (AYTU) recently declared that they have entered into a definitive merger agreement pursuant to which Neos will merge with a wholly owned subsidiary of Aytu in an all-stock transaction.

    Arbutus Biopharma Corporation (ABUS), a Biotechnology company, rose about 6.14% at $4.15 in pre-market trading Monday. The healthcare firm lately declared additional clinical data from an ongoing Phase 1a/1b clinical trial (AB-729-001) with AB-729, its proprietary GalNAc delivered RNAi compound.

    Greenwich LifeSciences Inc. (GLSI) lost over -16.07% at $47.0 in pre-market trading Monday December 14, 2020 following the publication of a second poster for the GP2 Phase III clinical trial design for recurring breast cancer at the San Antonio Breast Cancer Symposium (SABCS) in a virtual format.

    Veru Inc. (VERU) is up more than 19.12% at $7.57 in pre-market hours Monday December 14, 2020 following the company revealed positive Phase 2 clinical trial results for enobosarm, for the treatment of endocrine and chemotherapy resistant ER+/HER2- metastatic breast cancer. The stock had jumped over 6.45% to $6.36 in the last trading session.

    NanoVibronix Inc. (NAOV) stock plunged -6.36% to $1.03 in the pre-market trading after reporting that it has expanded and replaced its original distribution agreement with Ultra Pain Products, Inc..

    SELLAS Life Sciences Group Inc. (NASDAQ: SLS) shares are trading down -11.23% at $7.43 at the time of writing following the pricing of $16.2 million registered direct offering. Company’s 52-week ranged between $1.46 to $19.38.

  • 15 Trending Stocks in Biotechnology Industry

    15 Trending Stocks in Biotechnology Industry

    This year, biotech companies on the stock exchange have skyrocketed. This is no surprise since biotech firms are the leaders in the battle against the coronavirus pandemic. Even with Pfizer’s first vaccine in the UK, investors and pharmaceutical companies are well aware that the race is far ahead.
    Other diseases should not be ignored apart from coronavirus vaccines. The biotech sector is also creating headlines and innovating in areas linked to dementia, cancer, hereditary disorders, etc. Given the above, buyers are probably faced with the difficulty of choosing the best ones to purchase.

    Curis Inc. (NASDAQ:CRIS) shares were trading up 354.86% at $6.55 at the time of writing on Tuesday following announcement of proposed public offering of common stock.

    Curis Inc. (NASDAQ:CRIS) share price went from a low point around $0.62 to briefly over $3.59 in past 52 weeks, though shares have since pulled back to $6.55. CRIS market cap has remained high, hitting $409.70M at the time of writing, giving it price-to-sales ratio of more than 30.

    If we look at the recent analyst rating CRIS, Laidlaw initiated coverage on CRISshares with a Buy rating.

    Lexicon Pharmaceuticals Inc. (LXRX) last closed at $3.08, in a 52-week range of $1.03 to $5.33. Analysts have a consensus price target of $2.37. On November 17, 2020, the firmreported that both the SOLOIST and SCORED Phase 3 studies achieved their primary endpoints by demonstrating statistically significant reductions in total cardiovascular deaths, hospitalizations for heart failure and urgent heart failure visits in patients treated with sotagliflozin as compared with placebo.

    IGM Biosciences Inc. (IGMS) stock soar by 57.75% to $115.03 after declaringpricing of upsized $200 million public offering. The most recent rating by Robert W. Baird, on July 17, 2020, is at an Outperform.

    Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Shares headed rising, higher as much as 29.44%. The company will hold a conference call on Wednesday, December 9, 2020 at 10:00 a.m. ET to discuss clinical data from ongoing studies evaluating eganelisib in triple negative breast cancer (TNBC) The most recent rating by Oppenheimer, on June 27, 2019, is at an Outperform.

    Oncternal Therapeutics Inc. (NASDAQ:ONCT) rose 27.64% after gaining more than $1.1 on Tuesday after reporting updated interim clinical data from the ongoing Phase 1/2 CIRLL (Cirmtuzumab and Ibrutinib targeting ROR1 for Leukemia and Lymphoma) clinical trial.

    Proteostasis Therapeutics Inc. (PTI) last closed at $1.23, in a 52-week range of $0.87 to $4.72. The firm reported on November 16, 2020. a net loss of approximately $8.2 million for the three months ended September 30, 2020, as compared to a net loss of $12.8 million for the same period in the prior year.

    InflaRx N.V. (IFRX) stock soar by 18.27% to $4.79. The most recent rating by SVB Leerink, on November 06, 2020, is at an Outperform.

    Syros Pharmaceuticals Inc. (NASDAQ:SYRS) Shares headed rising, higher as much as 17.47% after closing $90.5 million strategic financing. The most recent rating by H.C. Wainwright, on November 04, 2020, is at a Buy.

    Aerpio Pharmaceuticals Inc. (NASDAQ:ARPO) rose 16.28% after gaining more than $0.28 on Tuesday.

    Ampio Pharmaceuticals Inc. (AMPE) last closed at $1.35, in a 52-week range of $0.31 to $1.39. The firm recently revealed that it will conduct its annual meeting in a virtual format only on December 12, 2020 at 9:00 am MST.

    Regulus Therapeutics Inc. (RGLS)stock soar by 15.19% to $0.93 following the closing of $19.4 million private placement of equity. The most recent rating by B. Riley FBR Inc., on March 28, 2018, is at a Neutral.

    Cancer Genetics Inc. (NASDAQ:CGIX) Shares headed rising, higher as much as 14.79%. The most recent rating by Maxim Group, on December 07, 2017, is at a Buy.

    Marinus Pharmaceuticals Inc. (NASDAQ:MRNS) fall -11.85% after losing more than -$1.85 on Tuesday. The healthcare firm lately declared pricing of $70 million public offering of common stock, which is expected to close on or about December 10, 2020.

    iBio Inc. (IBIO) last closed at $1.31, in a 52-week range of $0.19 to $7.45 after declaring pricing of $35 million public offering of common stock. Analysts have a consensus price target of $2.00.

    Vaccinex Inc. (VCNX) stock soar by 14.08% to $2.35. The most recent rating by BTIG Research, on September 23, 2020, is at a Neutral.

  • 20 Trending Stocks In Biotechnology Industry That Need Your Attention

    20 Trending Stocks In Biotechnology Industry That Need Your Attention

    Biotechnology is considered to be the backbone of many industrial sectors and it makes a significant contribution to the well being of society. Every single day we saw changes in every sector as we experience advancements of knowledge and the new technological breakthroughs.  One of the industries that constantly change is the biotechnology industry.

    2020 is the year of continuous development and improvement in drug research. This industry is the leading rapidly growing sector of the economy. There are various trends in the biotechnology industry that the world should expect in the coming years such as the production of personalized medicines thanks to the advancement in genetics and continuous development and improvement in drug research.

    Let’s take a quick look at the 20 leading companies which are following new trends in the biotechnology sector:

    Vaxart Inc. (NASDAQ: VXRT)

    Vaxart Inc. (NASDAQ: VXRT) shares were trading up 46.79% at $7.78 at the time of writing on Monday. Vaxart Inc. (NASDAQ: VXRT) share price went from a low point around $0.25 to briefly over $17.49 in the past 52 weeks, though shares have since pulled back to $7.78. VXRT market cap has remained high, hitting $766.25M at the time of writing, giving it a price-to-sales ratio of more than 90.

    Vaxart Inc. has revealed that the U.S. Food and Drug Administration (FDA) has completed its review of the Investigational New Drug (IND) application for its Phase 1 clinical trial evaluating its oral COVID-19 vaccine candidate. Vaxart Inc. also gave an update on its COVID-19 program.

    Cassava Sciences Inc. (NASDAQ: SAVA)

    Cassava Sciences Inc. (NASDAQ: SAVA) last closed at $7.75, in a 52-week range of $1.05 to $10.95. Cassava Sciences has announced the final results of a Phase 2bclinical study of Sumifilam in patients with Alzheimer’s Disease. Sumifilam is the first of a new class of drug compounds that bind to a protein called Filamin A. Cassava Sciences Inc. (SAVA) has earlier held a conference call on September 14.  Cassava Sciences Inc.’s market cap has remained high, hitting $182.51 million at the time of writing.

    Immunomedics Inc. (IMMU)

    Immunomedics Inc. (IMMU) stock soar by 97.99% to $83.65. The most recent rating by Barclays, on May 05, 2020, is at an Overweight. Gilead Sciences Inc. (NASDAQ: GILD) has earlier announced that it has decided to buy biotech company Immunomedics Inc for $21 billion. This decision will strengthen its cancer portfolio by gaining access to a promising drug.  Immunomedics Inc. (IMMU) has a total market capitalization of $19.19 billion.

    Sorrento Therapeutics Inc. (NASDAQ: SRNE)

    Sorrento Therapeutics Inc. (NASDAQ: SRNE) shares headed rising, higher as much as 17.88%. The most recent rating by H.C. Wainwright, on July 31, 2020, is at a Buy. Sorrento Therapeutics Inc. (NASDAQ: SRNE) has earlier disclosed that it has signed an exclusive license agreement with Mayo Clinic for an antibody-drug-nanoparticle albumin-bound (nab) immune complexes (ADNICs) platform targeting many types of human diseases including various solid and liquid tumors. Sorrento Therapeutics Inc. has a market cap of $1.86 billion.

    Novan Inc. (NASDAQ: NOVN)

    Novan Inc. (NASDAQ: NOVN) rose 13.00% after gaining more than $0.06 on Monday. Novan Provides Pipeline and Priority Development Programs Update. Novan Inc. (NOVN) gave a pipeline and priority development programs update. Novan Inc.’s share price went from a low point around $0.22 to briefly over $3.72 in the past 52 weeks, though shares have since pulled back to $0.53. Novan Inc.’s market cap has remained high, hitting $82.02 million at the time of writing.

    Inovio Pharmaceuticals Inc. (NASDAQ: INO)

    Inovio Pharmaceuticals Inc. (NASDAQ: INO) stock soar by 12.30% to $11.32. The most recent rating by ROTH Capital, on July 01, 2020, is at a Sell. Inovio Pharmaceuticals Inc. (INO) has earlier signed a manufacturing agreement with Thermo Fisher Scientific. Thermo Fisher Scientific has signed a letter of intent to manufacture INOVIO’s DNA COVID-19 vaccine candidate INO-4800.

    Evofem Biosciences Inc. (NASDAQ: EVFM)

    Evofem Biosciences Inc. (NASDAQ: EVFM) Shares headed rising, higher as much as 11.90% after Evofem Biosciences to present data at the 2020 STD prevention Virtual Conference from Phase 2b Trial of EVO100 for prevention of Chlamydia and Gonorrhea in Women. The most recent rating by Morgan Stanley, on August 20, 2020, is at an Equal-weight.

    iBio Inc. (AMEX: IBIO)

    iBio Inc. (AMEX: IBIO) rose 9.28% after gaining more than $0.18 on Monday. iBio Inc. (AMEX: IBIO) has earlier disclosed that it has selected IBIO-201, its LicKM-ubunit vaccine, as its leading candidate for the prevention of SARS-CoV-2 infection. iBio revealed earlier the preclinical immunization studies with IBIO-200 and IBIO-201, combined with select adjuvants from the Infectious Disease Research Institute, induced anti-SARS-CoV-2 antibodies.  iBio Inc has a market capitalization of $379.31 million.

    Clovis Oncology Inc. (CLVS)

    Clovis Oncology Inc. (CLVS) last closed at $7.00, in a 52-week range of $2.93 to $17.37. CLVS has traded up 138.91% from its 52-weeks low and traded down -59.70% from its 52-weeks high. Analysts have a consensus price target of $9.00. Clovis Oncology Inc. (CLVS) has earlier announced Oral Plenary Session Presentation at the International Gynecologic Cancer Society (IGCS)digital annual global meeting.

    Heat Biologics Inc. (NASDAQ: HTBX)

    Heat Biologics Inc. (NASDAQ: HTBX) stock soar by 1.82% to $1.12. The most recent rating by ROTH Capital, on June 20, 2016, is at a Buy. Heat Biologics Inc. (HTBX) has earlier participated in a virtual panel, entitled, “New Approaches to COVID-19: Hidden Breakthroughs,” being held on Thursday, September 10. Heat Biologics has also issued a key patent on combination platform therapy. Heat Biologics Inc. has a total market capitalization of $170.96 million.

    VBI Vaccines Inc. (NASDAQ: VBIV)

    VBI Vaccines Inc. (NASDAQ: VBIV) shares headed rising, higher as much as 12.82% after VBI Vaccines to present additional biomarker data from VBI-1901 Phase 1/2a Study in Recurrent GBM in an E-Poster at ESMO Virtual Congress 2020. The most recent rating by Raymond James, on August 27, 2020, is at a Strong buy. Its market capitalization has remained high, hitting $813.82 million.

    Dynavax Technologies Corporation (NASDAQ: DVAX)

    Dynavax Technologies Corporation (NASDAQ: DVAX) rose 13.37% after gaining more than $0.67 on Monday. Valneva and Dynavax have announced a Commercial supply agreement for Inactivated, adjuvanted COVID-19 vaccine. This is a commercial partnership for the supply of Dynavax’s CpG 1018 adjuvant for use in Valneva’s SARS-CoV-2 vaccine candidate, VLA2001. Dynavax will supply CpG 1018 to produce up to 100 million doses of vaccine in 2021. Valneva has the opportunity to purchase up to an additional 90 million doses through 2025.

    Zosano Pharma Corporation (NASDAQ: ZSAN)

    Zosano Pharma Corporation (NASDAQ: ZSAN) last closed at $1.72, in a 52-week range of $0.41 to $2.45. Zosano Pharma Corporation (ZSAN) is scheduled to participate in a Cantor Virtual Global Healthcare Conference on Tuesday, September 15, 2020. At the conference, Zosano Pharma Corporation will present the company overview. Zosano Pharma Corporation has a total market capitalization of $138.86 million at the time of writing.

    Moderna Inc. (NASDAQ: MRNA)

    Moderna Inc. (NASDAQ: MRNA) stock soar by 7.30% to $63.67. The most recent rating by SVB Leerink, on September 08, 2020, is at an Underperform. Moderna Inc. (MRNA) has earlier named Michael Millette as Managing Director, Canada effective immediately. Michael Millette has joined Moderna Inc in August 2020 as Vice President. Moderna Inc has a total market cap of $24.37 billion at the time of writing.

    9 Meters Biopharma Inc. (NASDAQ: NMTR)

    9 Meters Biopharma Inc. (NASDAQ: NMTR) Shares headed rising, higher as much as 12.61%. 9 Meters Biopharma Inc. (NASDAQ: NMTR) is scheduled to participate in the upcoming two conferences in September including H.C. Wainwright: 22nd Annual Global Investment Conference and Oppenheimer Fall Healthcare Life Sciences & MedTech Summit. These two conferences are scheduled to take place on September 15 and September 23, respectively.

    Ampio Pharmaceuticals Inc. (AMEX: AMPE)

    Ampio Pharmaceuticals Inc. (AMEX: AMPE) rose 10.80% after gaining more than $0.08 on Monday. Ampio Pharmaceuticals Inc. (AMPE) has revealed positive results in the early trial for intravenous Ampion treatment for COVID-19 patients on September 9, 2020. The Phase I trial was continued in the supervision of Michael Roshon, MD, Ph.D., Chief of Staff at Penrose-St. Francis Hospital in Colorado Springs, Colorado.

    Novavax Inc. (NASDAQ: NVAX)

    Novavax Inc. (NASDAQ: NVAX) last closed at $105.80, in a 52-week range of $3.54 to $189.40. Novavax Inc. (NVAX) is scheduled to participate in the upcoming three conferences including Cantor Virtual Global Healthcare Conference, Morgan Stanley Virtual 18th Annual Global Healthcare Conference, and Leerink CyberRx Series: Vaccine Forum on September 15, 16, and 23, respectively. It has earlier participated in Citi 15th Annual BioPharma Virtual Conference, and H.C. Wainwright 22nd Annual Global Investment Conference on September 10, and 14, 2020, respectively.

    Marinus Pharmaceuticals Inc. (NASDAQ: MRNS)

    Marinus Pharmaceuticals Inc. (NASDAQ: MRNS) stock soar by 5.50% to $2.11. The most recent rating by H.C. Wainwright, on July 01, 2020, is at a Buy. Marinus Pharmaceuticals Inc. (MRNS)has disclosed that it has entered into a five-year development contract with the Biomedical Advanced Research and Development Authority (BARDA) to support the development of IV ganaxolone for the treatment of refractory status epilepticus (RSE).

    Onconova Therapeutics Inc. (NASDAQ: ONTX)

    Onconova Therapeutics Inc. (NASDAQ: ONTX) Shares headed falling, lower as much as -3.28%. The most recent rating by H.C. Wainwright, on March 01, 2018, is at a Buy. Onconova Therapeutics Inc. (NASDAQ: ONTX) has earlier participated in two virtual events including Marcus Evans Healthcare Investment Webinar on September 10 and H.C. Wainwright 22nd Annual Global Investment Conference onSeptmerb 14. It is scheduled to participate in the 2nd Annual RAS-Targeted Drug Development Conference on September 16, 2020.

    Trevena Inc. (NASDAQ: TRVN)

    Trevena Inc. (NASDAQ: TRVN) last closed at $2.08, in a 52-week range of $0.46 to $3.68. In the past 52-weeks of trading, Trevena Inc. (TRVN) stock fluctuated between the low of $0.46 and a high of $3.68. It has moved up $352.17% from its 52-weeks low and moved down -43.48% from its 52-weeks high. Its market capitalization is $306.38 million at the time of writing.

     

  • 15 Trending Stocks in Biotechnology Industry

    15 Trending Stocks in Biotechnology Industry

    The biggest movers of the 2020 are biotech stocks. Now, the COVID-19 pandemic has put brighter spotlight on the future of healthcare and specially biotech stocks have respond accordingly.

    Innovative biotech business have adopted the change and are competing to make what could become a life-saving treatment for millions in the form of a vaccine.

    Some of the biggest winners of this transformative mega-trend are discussed below.

    Genocea Biosciences Inc. (NASDAQ:GNCA) shares were trading up 24.44% at $4.48 at the time of writing on Friday.

    Genocea Biosciences Inc. (NASDAQ:GNCA) share price went from a low point around $1.10 to briefly over $3.86 in past 52 weeks, though shares have since pulled back to $4.48. GNCA market cap has remained high, hitting $99.50M at the time of writing, giving it price-to-sales ratio of more than 110.

    If we look at the recent analyst rating GNCA, SVB Leerink initiated coverage on GNCA shares with an Outperform.

    Arbutus Biopharma Corporation (ABUS) last closed at $4.96, in a 52-week range of $0.82 to $6.48. Analysts have a consensus price target of $5.00.

    Ocugen Inc. (OCGN) stock soar by 32.85% to $0.38.

    Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Shares headed falling, lower as much as -3.97%. The most recent rating by ROTH Capital, on April 18, 2019, is at a Buy.

    Capricor Therapeutics Inc. (NASDAQ:CAPR) rose 29.31% after gaining more than $1.75 on Friday.

    Ampio Pharmaceuticals Inc. (AMPE) last closed at $0.96, in a 52-week range of $0.26 to $0.97.

    iBio Inc. (IBIO) last closed at $5.50, in a 52-week range of $0.05 to $7.45.

    Novan Inc. (NOVN) stock soar by 6.06% to $0.86. The most recent rating by Piper Jaffray, on January 06, 2020, is at a Neutral.

    Onconova Therapeutics Inc. (NASDAQ:ONTX) Shares headed falling, lower as much as -2.63%. The most recent rating by H.C. Wainwright, on March 01, 2018, is at a Buy.

    Actinium Pharmaceuticals Inc. (AMEX:ATNM) rose 7.45% after gaining more than $0.03 on Friday.

    Sesen Bio Inc. (SESN) last closed at $0.99, in a 52-week range of $0.37 to $1.54.

    VistaGen Therapeutics Inc. (VTGN) stock drop by -4.39% to $0.76. The most recent rating by Maxim Group, on June 27, 2018, is at a Buy.

    Qualigen Therapeutics Inc. (NASDAQ:QLGN) Shares headed rising, higher as much as 11.22%.

    PolarityTE Inc. (NASDAQ:PTE) rose 10.56% after gaining more than $0.17 on Friday.

    Matinas BioPharma Holdings Inc. (MTNB) last closed at $0.96, in a 52-week range of $0.49 to $2.49.